CIK 0001553643
- Non-accelerated filer
- Smaller reporting company
RELMADA THERAPEUTICS, INC.
Sign in to watch- Ticker
- RLMD
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- NV
- Entity type
- Operating
- EIN
- 455401931
- Phone
- +1 646-876-3459
- Business address
- 2222 PONCE DE LEON BLVD. 3RD FLOOR, CORAL GABLES, FL, 33134
- Former names
- CAMP NINE, INC.
- 4 Open-market sale Director sold 5,000 shares at an average $35.71 ($178,551)
- 4 Open-market sale CFO sold 10,000 shares at an average $35.45 ($354,507)
- 4 Open-market sale Director sold 3,000 shares at $33.87 ($101,618)
- 4 Open-market sale CEO sold 10,000 shares at an average $34.24 ($342,392)
- 4 Open-market sale Director sold 5,000 shares at an average $34.19 ($170,933)
- 4 Open-market sale CFO sold 3,000 shares at an average $34.18 ($102,529)
- 4 Exercise or conversion Director acquired 5,000 shares (option exercise)
- 4 Open-market sale CEO sold 1,446 shares at $35.43 ($51,238)
- 4 Open-market sale CFO sold 1,428 shares at $35.39 ($50,542)
- 4 Open-market sale CEO sold 11,206 shares at an average $35.17 ($394,085)
- 4 Open-market sale Director sold 3,569 shares at an average $35.18 ($125,565)
- 4 Open-market sale CFO sold 11,372 shares at an average $35.17 ($399,910)
- 4 Exercise or conversion CEO acquired 13,281 shares (option exercise)
- 4 Open-market sale CEO sold 3,278 shares at an average $35.07 ($114,970)
- 4 Open-market sale CFO sold 3,200 shares at an average $35.04 ($112,134)
- 4 Open-market sale Director sold 2,346 shares at an average $35.04 ($82,203)
- 4 Open-market sale Director sold 3,000 shares at an average $33.63 ($100,898)
- 4 Open-market sale CFO sold 3,000 shares at an average $31.93 ($95,778)
- 4 Open-market sale CEO sold 10,000 shares at an average $32.39 ($323,914)
- 4 Open-market sale Director sold 5,000 shares at an average $32.46 ($162,323)
Page 6 of 10 · 200 filings